Good Quality Fenbendaozle - Albendazole 2.5% + ivermectin suspension – Depond
Good Quality Fenbendaozle - Albendazole 2.5% + ivermectin suspension – Depond Detail:
Composition:
Each liter contains
Albendazole 25mg
Ivermectin 1g
Cobalt Sulfate 620mg
Sodium Selenite 270mg
Indication:
Used for the treatment and prevention from external and internal infection caused by the parasites in cattle, camel, sheep and goats.
Gastrointestinal nematodes: ostertagia sp., haemonchus sp., trichostrongylus sp., cooperia sp., oesophagostomum sp., bunostomun sp. And chabertia sp.
Tenia: Monieza sp.
Pulmonary Enterobiasis: Dictyocaulus viviparous.
Hepatic Fasciola: Fasciola hepatica.
Usage and dosage:
Unless recommended otherwise by veterinarian:
For Cattle and Camels: It is administered at a dose of 15ml/50kg body weight and for hepatic fasciola, it is administered at a dose of 20ml/50kg body weight.
For sheep and goats: It is administered at a dose of 2ml/10kg body weight and for hepatic fasciola, it is administered at a dose of 20ml/ 50kg of body weight, it is only orally administered.
Product detail pictures:
Related Product Guide:
Our mission is to become an innovative supplier of high-tech digital and communication devices by providing value added design, world-class manufacturing, and service capabilities for Good Quality Fenbendaozle - Albendazole 2.5% + ivermectin suspension – Depond , The product will supply to all over the world, such as: Saudi Arabia, Rotterdam, Uruguay, Besides there are also professional production and management , advanced production equipment to assure our quality and delivery time , our company pursues the principle of good faith, high-quality and high-efficiency. We guarantee that our company will try our best to reduce customer purchase cost, shorten the period of purchase, stable products quality, increase customers' satisfaction and achieve win-win situation .
It can be said that this is a best producer we encountered in China in this industry, we feel lucky to work with so excellent manufacturer.






